Syndeio Biosciences
- Biotech or pharma, therapeutic R&D
Clinical-stage biotech company developing synapse-targeted therapies in Phase 2 development supported by novel Boost pharmacology platform
Clinical-stage biotech company developing synapse-targeted therapies in Phase 2 development supported by novel Boost pharmacology platform